Metastatic Colon Cancer Recurring After Cetuximab Plus Doublet Chemotherapy Harboring Acquired G12C Mutant that Responded to Sotorasib Plus Cetuximab.

Chang, Ching-ChengChing-ChengChangYI-HSIN LIANGKUO-HSING CHENBEEN-REN LINKUN-HUEI YEH2025-05-082025-05-082025-04-01https://scholars.lib.ntu.edu.tw/handle/123456789/729167en[SDGs]SDG3Metastatic Colon Cancer Recurring After Cetuximab Plus Doublet Chemotherapy Harboring Acquired G12C Mutant that Responded to Sotorasib Plus Cetuximab.journal article10.1200/PO-24-0060940249882